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The effect of a concurrent herpes simplex virus (HSV) infection on human immunodeficiency virus type 1 (HIV-1) load was evaluated. Sixteen subjects were identified with an active HSV infection and had pre-outbreak, acute-phase, and post-outbreak plasma (n Å 16) and peripheral blood mononuclear cell (PBMC) (n Å 8) samples for evaluation. All subjects were treated for an acute HSV outbreak with acyclovir for 10 days, followed by chronic prophylaxis. HIV-1 plasma RNA levels were determined by branched DNA, and intracellular HIV gag mRNA copy numbers were determined by quantitative reverse transcriptase -polymerase chain reaction ELISA. Plasma virus load increased a median of 3.4-fold during the acute outbreak (range, 0-to 10-fold; P Å .002), while post-outbreak levels (30 -45 days after the appearance of lesions) remained above pre-outbreak, baseline levels in some subjects. Intracellular HIV gag mRNA increased during the outbreak as well. Thus, an acute HSV episode can result in increased HIV transcription and plasma virus load.
Human immunodeficiency virus (HIV) infection results in
HIV or enhance replication [1 -4] . A direct correlation between HSV infection and increased HIV burden in patients has not destruction of the immune system, leading to profound immunosuppression and the development of opportunistic infections. been described. Recently, plasma HIV load measurement was found to be It is unclear whether opportunistic infections contribute directly to HIV clinical progression through T cell activation with subimportant in predicting disease progression or response to antiretroviral therapy [5, 6] . In addition, opportunistic infections, sequent HIV replication or through T cell destruction (or both). Reactive herpes simplex virus (HSV) infections are found with bacterial pneumonia including tuberculosis, interleukin-2 immunotherapy, and immunizations have all been associated with increased frequency in HIV-infected patients. In vitro and possibly in vivo studies suggest that HSV-1 can activate latent increased HIV load [7 -12] . In the current study, we wished to determine whether HIV load changed significantly in subjects with active HSV infection. The post-outbreak plasma HIV-1 RNA level was greater than gag gene PCR product (SK38 and SK39) was quantitated with an that at baseline in 10 of 16 subjects (P Å .14). ral therapy than in those who were (121,000 vs. 53,500/mL; P Å .02). PBMC samples for all three time points were available for Results only 8 subjects. PBMC mRNA was detectable and quantifiable in 4 of 8 subjects before the HSV outbreak, in 8 of 8 during Thirty-six subjects were identified as having probable or confirmed HSV infection. Sixteen male subjects were identified the acute episode, and in 7 of 8 following the acute episode ( figure 1C ). Thus, 3 subjects changed from having undetectable who had experienced an active infection with cutaneous or mucocutaneous HSV infection and for whom plasma or PBMC to detectable levels in their PBMC during the outbreak. The 4 subjects with measurable cellular mRNA at all three collection samples were available for all three time points. Clinical characteristics of the subjects are provided in table 1. None of the points had median mRNA levels of 299, 837, and 396 copies of HIV-1 gag mRNA/mg of PBMC RNA in baseline, acute, subjects were receiving chronic acyclovir prophylaxis on entry to the study. Eight subjects had received continuous antiretroviand post-outbreak periods, respectively. ral therapy (2 zidovudine, 2 didanosine, 4 combination) for at least 3 months before and throughout this study. Five subjects Discussion had positive HSV cultures from lesions. Eleven subjects were presumed to have HSV infections on the basis of a clinical
The data presented here demonstrate that HIV RNA levels can increase during active HSV infection. The level of increase presentation of vesicular or ulcerative lesions and a previous episode with a positive HSV culture. One subject was HSV is greater than one would expect as a result of biologic or assay variability [14] . We found that while this increase was transient culture -negative but Tszank smear -positive. Subtype of HSV was not reported by the reference laboratory at the time. At in conjunction with the clinical resolution of the herpetic le-/ 9d31$$se29 07-24-97 11:56:02 jinfa UC: J Infect sions and acyclovir therapy, the levels for both plasma HIV-1 effective antiretroviral therapy still demonstrate these increases remains to be studied. RNA and cellular mRNA did not return to baseline for all subjects during the time period studied. Since all of our patients
We have demonstrated that HIV load first increases and then decreases in the weeks surrounding an acute HSV episode in received acyclovir therapy followed by chronic prophylaxis, it was not possible to determine whether an acute HSV exacerbathe presence of acyclovir therapy and subsequent prophylaxis.
Since this increase appears to be short-term, the overall impact tion results in only a transient rise in HIV load or, if left untreated, would have resulted in a sustained increase. Alon the individual patient may not be great. Similar short-term increases in HIV plasma RNA levels have been reported for though few clinical data have been published, reports to date suggest that the up-regulation of HIV-1 expression induced by HIV-seropositive patients with other coinfections [7 -9], patients receiving immunomodulators such as interleukin-2 [10], HSV in vitro [1 -3] and in vivo [4] may translate to increased plasma HIV-1 RNA levels.
and patients receiving immunizations with tetanus toxoid and pneumococcal vaccine [11, 12] . Serial samples collected after The magnitude of virus load response may be related to the size, extent, or length of time that HSV lesions are present or immunization with tetanus toxoid or pneumococcal vaccination suggest that virus load elevations of 2-to 100-fold are transient to concomitant antiherpetic or antiretroviral therapy. Schaker et al. [15] found a smaller median increase (51% over baseline) in nature and may be related to HIV status (CD4 cell count, degree of immunosuppression) or antibody response. The perin HIV-1 plasma RNA in the days surrounding an acute HSV-2 event. Semple et al. [16] reported on 1 subject with centage of activated T cells was also increased. Bush et al. [7] found that in 13 subjects with bacterial pneumonia, plasma focal disease who had a 10-fold transient increase in virus load during an HSV infection. No details regarding acyclovir virus load increased by a mean of 0.5 log 10 (3-fold) compared to pre-pneumonia levels. Donovan et al. [8] found that in a therapy were provided. We found greater HIV load increases in those subjects who were not receiving antiretroviral therapy.
small series of patients with active opportunistic infections, virus load transiently increased by an average of 7-fold (0.85 Whether subjects with undetectable virus load as a result of / 9d31$$se29 07-24-97 11:56:02 jinfa UC: J Infect / 9d31$$se29 07-24-97 11:56:02 jinfa UC: J Infect
